Pharmafile Logo
Pharmafocus logo
Advanced Search

Teva

Showing 15 posts of 233 posts found.

Celltrion and Teva’s Herceptin biosimilar secures FDA approval in breast cancer

December 18, 2018
Manufacturing and Production, Sales and Marketing Herceptin, Herzuma, Teva, celltrion, pharma

Israeli and South Korean-based drug makers Teva and Celltrion are set to move in on the market share occupied by …

News

Generics firms investigated for their involvement in the ‘largest cartel in the history of the United States’

December 11, 2018
Manufacturing and Production Dr Reddy's, Mylan, Teva, US, corruption, generics, price fixing, price-fixing, sun

At least 16 generic drugmakers are being investigated for their involvement in what has been described as the “largest cartel …

News

FDA approves first Rituxan biosimilar courtesy of Teva and Celltrion

November 29, 2018
Sales and Marketing FDA, Genentech, Rituxan, Roche, Teva, Truxima, biosimilars, celltrion

The FDA has announced the first US approval of a biosimilar version of Genentech’s Rituxan (rituximab), awarding marketing approval to …

News
epipen

Teva’s EpiPen generic retails for same price as Mylan’s own

November 28, 2018
Research and Development, Sales and Marketing Mylan, Teva, epipen, pharma

Israeli generics firm Teva has revealed the price tag of its generic version of Mylan’s EpiPen epinephrine auto-injector, and, at …

News
sicorbio

FDA greenlights Teva’s migraine drug Ajovy in two dosage options

September 20, 2018
Sales and Marketing FDA, Teva, US, ajovy, migraine, pharma

Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval as a …

News
teva_copy

Teva shares soar after migraine treatment Ajovy approval

September 17, 2018
Sales and Marketing FDA, Teva, US, ajovy, approval, israel

Shares in the Israeli pharma firm Teva soared on Sunday after the announcement that the US Food and Drug Administration …

News
john_nason

Teva names new President, TAPI and Biologics Operations

September 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Novartis, Teva, appointment

Israeli generic drug specialist Teva has announced its appointment of John Nason in a multi-faceted role as President of Teva …

Appointment
teva_canada_1

Teva drops MS and Huntington’s disease drug laquinimod, leaving rights to Active Biotech

September 6, 2018
Medical Communications, Research and Development Active Biotech, Laquinimod, Teva, pharma

Israeli multinational Teva Pharmaceutical has decided to discontinue the development of laquinimod. As such, all rights for the orally administered …

News
hero-plus

FDA approves first-ever generic EpiPen versions, courtesy of Teva

August 17, 2018
Medical Communications, Sales and Marketing FDA, Mylan, Teva, US, epipen, pharma

The FDA has announced the approval of the first generic versions of Mylan’s EpiPen and EpiPen Jr epinephrine auto-injectors as …

News
sicorbio

Teva to relocate US HQ to New Jersey, affecting over 1,000 jobs

July 6, 2018
Manufacturing and Production, Medical Communications Teva, US, new jersey, pharma, philadelphia

As the Israeli firm presses on with attempts to cut back on costs and streamline operations, Teva has announced plans …

News
teva_copy

Teva axes Phase 3 trial into chronic cluster headache

June 18, 2018
Research and Development, Sales and Marketing Teva, fremanezumab, headache, pharma

With the advent of another week, there’s another trial discontinuation in the industry as Teva announces its decision to terminate …

News

New Jersey attempts to lure Teva HQ with tax incentives

June 15, 2018
Medical Communications Teva, biotech, drugs, pharma, pharmaceutical

Teva has been doing some major global restructuring since Kare Schultz came to the helm of the embattled, Israeli drugmaker. …

News
shutterstock_273326141

Axovant snatches Teva and Allergan execs to strengthen management

June 5, 2018
Manufacturing and Production, Medical Communications Allergan, Axovant, Teva, appointment, pharma

Axovant has announced reinforcements to its management team with two new additions, snatching up Allergan’s current Chief Medical Officer Dr …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

April 13, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Cancer, Humira, Mylan, Novartis, Shire, Takeda, Teva, acquisition, cystic fibrosis, hepatitis C, pharma, top ten

It’s Friday the 13th, but that doesn’t change a strong showing from the industry this week as it continued to …

News
mylan

Mylan looks to hit Teva where it hurts, eyeing slow-release MS treatment

April 11, 2018
Research and Development, Sales and Marketing Copaxone, Mapi Pharma, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Mylan has taken several steps recently that seem intended to hit sales of its big rivals on their key products, …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023